Cargando…
Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer
Immunotherapy is revolutionising cancer treatment and has already emerged as standard treatment for patients with recurrent or metastatic gastric cancer (GC). Recent research has been focused on identifying robust predictive biomarkers for GC treated with immune checkpoint inhibitors (ICIs). The exp...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440716/ https://www.ncbi.nlm.nih.gov/pubmed/32817133 http://dx.doi.org/10.1136/esmoopen-2020-000791 |